Biotech & Pharma
Health Tech
Business & Policy
Health & Science
Team
Exclusive analysis of biotech, pharma, and the life sciences
Topics
Columns
Tools
Events
Team
Account
More
Follow Us
By Damian Garde , Meg Tirrell and Adam Feuerstein April 28, 2022
Can rewired cells cure some patients’ cancer? Do biotech stocks ever go up? And why’s it taking so long to get kids vaccinated for Covid-19?
We cover all that and more this week on “The Readout LOUD,” STAT’s biotech podcast. Immunologist Katy Rezvani of MD Anderson Cancer Center joins us to explain the massive potential of a new approach to treating wily tumors, one that repurposes human immune cells. We also discuss the latest news in the life sciences, including an interesting hire at Novartis, the pediatric Covid-19 vaccine saga, and another negative milestone for biotech.
For more on what we cover, here’s the latest on NK cells for cancer; here’s where you can subscribe to the First Opinion Podcast; and here’s our complete coverage of the Covid-19 pandemic.
advertisement
Be sure to sign up on Apple Podcasts, Stitcher, Google Play, or wherever you get your podcasts.
And if you have any feedback for us — topics to cover, guests to invite, vocal tics to cease — you can email [email protected].
advertisement
Interested in sponsoring a future episode of “The Readout LOUD”? Email us at [email protected].
National Biotech Reporter
Damian covers biotech, is a co-writer of The Readout newsletter, and a co-host of “The Readout LOUD” podcast.
Co-host “The Readout LOUD,” CNBC senior health and science reporter
Senior Writer, Biotech
Adam is STAT’s national biotech columnist, reporting on the intersection of biotech and Wall Street. He’s also a co-host of “The Readout LOUD” podcast.
biotechnology
cancer
Vaccines
This name will appear with your comment
There was an error saving your display name. Please check and try again.
By Damian Garde, Meg Tirrell and Adam Feuerstein
By Damian Garde, Meg Tirrell and Adam Feuerstein
advertisement
By Ed Silverman
By Katie Palmer, Mario Aguilar and J. Emory Parker
By Katie Palmer and Mario Aguilar
Reporting from the frontiers of health and medicine